U.S., May 2 -- ClinicalTrials.gov registry received information related to the study (NCT07561086) titled 'Innovative Insulin Injection Sites Map to Minimize Lipohypertrophy Risk' on April 26.
Brief Summary: Background:
Patients on long-term insulin therapy frequently develop a condition called lipohypertrophy (LH), which involves the accumulation of abnormal fatty tissue at insulin injection sites. This condition is caused by repeated injections in the same area and can lead to inconsistent insulin absorption, unpredictable blood sugar levels, and increased risks of hypoglycemia and hyperglycemia. While standard care often includes verbal instructions on site rotation, many patients continue to struggle with technique and develop these c...